Minnesota 2023-2024 Regular Session

Minnesota Senate Bill SF2727

Introduced
3/8/23  

Caption

Cause of action authorization for remedy of medical monitoring

Impact

If enacted, SF2727 would significantly impact state laws by allowing for medical monitoring claims related to toxic exposure that might previously have been limited to those with manifest diseases. This change suggests a broader interpretation of liability in cases of environmental health risks, encouraging proactive healthcare measures in communities affected by hazardous materials. Legal practitioners would need to adapt to the new standards established by this bill in terms of how exposure cases are argued and what evidence is required to demonstrate potential health risks.

Summary

SF2727 proposes a new cause of action for individuals exposed to proven toxic substances, allowing them to seek medical monitoring even without currently having a present injury or disease. The bill defines 'medical monitoring' as a program of medical tests aimed at early detection of diseases linked to such exposures. Importantly, this legislation seeks to hold owners or operators of large facilities accountable when their operations release toxic substances, thus extending liability and providing recourse for individuals at increased health risk due to their proximity to these operations.

Contention

Notable points of contention around SF2727 include concerns from industry groups, who argue that the bill may lead to excessive litigation and impose onerous costs on businesses, particularly in how they manage chemical substances. Opponents of the bill fear that it could hinder economic growth by creating an environment of fear over potential litigation, thereby stifling industrial progress or investment in certain regions. Supporters of the bill, however, argue that it is essential to protect public health and provide necessary resources for those at risk from hazardous exposures, thereby emphasizing the ethical need for health monitoring and environmental safety.

Companion Bills

MN HF2794

Similar To Cause of action authorized for remedy of medical monitoring.

Previously Filed As

MN S07474

Establishes a cause of action for medical monitoring for a person with or without a present injury or disease; establishes a statute of limitation for such cause of action.

MN HB2888

Establishes provisions relating to actions brought for medical monitoring

MN SB1621

Establishes provisions relating to civil actions involving medical monitoring

MN HB4637

Civil procedure: civil actions; action for medical monitoring for individuals exposed to a proven toxic substance; provide for. Amends secs. 20126 & 20140 of 1994 PA 451 (MCL 324.20126 & 324.20140) & adds sec. 20136.

MN SB0386

Civil procedure: civil actions; action for medical monitoring for individuals exposed to a proven toxic substance; provide for. Amends secs. 20126 & 20140 of 1994 PA 451 (MCL 324.20126 & 324.20140) & adds sec. 20136.

MN A2281

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

MN S3006

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

MN HB2414

Remedial groundwater incentives; PFAS

MN HF2313

Geolocation and smartphone monitoring of another person prohibited, and cause of action when violation has occurred provided.

MN SF3240

Certain health care facilities electronic monitoring authorization provision

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.